Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 7, 2004
Reporting Period: Thirteen weeks ended August 28, 2004
This filing serves to announce the company's financial results for the specified thirteen-week period via a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover document referencing a press release and does not contain specific numerical data. Consequently, the filing text does not provide clear values for:
- Revenue
- Profit or Net Income
- Cash Flow
- Margins
- Debt Levels
- Liquidity Positions
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. It explicitly states that the information is incorporated by reference from the attached press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual financial figures for the thirteen weeks ended August 28, 2004.
- Verify year-over-year and quarter-over-quarter performance metrics in the attached press release.
- Check for any forward-looking statements or guidance included in the press release that are not present in this 8-K summary.
- Confirm the status of any legal or regulatory contingencies mentioned in the full press release.